The U.S. Food and Drug Administration on Wednesday issued thirteen new import alerts targeting flavored disposable vapes, marking the agency's most aggressive enforcement action since the 2020 deeming rule. The list includes several products with reported U.S. sales exceeding $40 million annually — devices that, until this week, retailers had treated as compliant by default.
Wednesday's action arrives after eighteen months of mounting pressure from public-health groups over the agency's perceived inability to clear shelves of devices that had never received Premarket Tobacco Product Authorization. The brands named — including several with deep U.S. distribution networks and one publicly-traded parent company — had previously evaded enforcement through importer-of-record substitution and packaging changes.
"This is the first time we've seen FDA name parent companies, not just SKUs," said Dr. Amanda Reilly of the Tobacco Control Resource Library. "It changes the calculus for any retailer still moving these products."
What the alerts actually do
Import alerts authorize CBP to detain shipments at the border without physical examination. The named products are now subject to Detention Without Physical Examination (DWPE) under nine separate HS codes, including the new ENDS-specific code added in last year's appropriations bill.
For products already in U.S. distribution, the alerts do not require recall — but they do trigger a chain reaction. Retailers carrying named SKUs typically pull stock within 14–21 days to limit liability exposure. Distributors face contractual indemnification claims from those retailers. And manufacturers lose the ability to replenish inventory.
"This is the first time we've seen FDA name parent companies, not just SKUs. It changes the calculus for any retailer still moving these products."Dr. Amanda Reilly, Tobacco Control Resource Library
The 60-day question
Industry trade groups responded within hours, pointing to FDA's own historical guidance that established a typical 60-day window for retailers to clear unauthorized inventory. That guidance, however, is non-binding — and recent enforcement actions in California and Massachusetts have set a much shorter clock.
What retailers should do now
VapeRisk's policy team has reviewed the alerts and the parallel state-level actions in five jurisdictions. Based on enforcement patterns from the 2024 Juul and Vuse settlements, we recommend retailers carrying named SKUs treat Wednesday's date as the start of a 21-day clearance window, not 60.
- Audit current inventory against the full list (linked at the top of this article)
- Pause reorders on any device with shared parent-company manufacturing
- Document destruction or return-to-distributor for tax and liability purposes
- Review state-specific PACT Act reporting obligations triggered by stock changes
What comes next
FDA officials, speaking on background, indicated that Wednesday's list represents "phase one" of a larger enforcement plan. Internal communications obtained by VapeRisk reference a second tranche under review, focused on synthetic nicotine products that were excluded from the original 2022 omnibus sweep.
Whether that second tranche arrives before the agency's August reorganization remains the most consequential open question for the U.S. vape industry this year. VapeRisk will update this article as enforcement actions develop.
Updates
2:14 PM ET — Lost Mary's parent company, Heaven Gifts Trading, issued a statement disputing the alert's basis and indicating it will file a Section 304 petition by Friday. 5:30 PM ET — Three additional state attorneys general have signaled parallel UDAP investigations.